Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Vaccines and Antiviral Agents

Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine

Bruce A. Mungall, Deborah Middleton, Gary Crameri, John Bingham, Kim Halpin, Gail Russell, Diane Green, Jennifer McEachern, L. Ian Pritchard, Bryan T. Eaton, Lin-Fa Wang, Katharine N. Bossart, Christopher C. Broder
Bruce A. Mungall
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Middleton
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary Crameri
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Bingham
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim Halpin
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail Russell
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diane Green
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer McEachern
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Ian Pritchard
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryan T. Eaton
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin-Fa Wang
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katharine N. Bossart
1CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, Victoria 3220, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher C. Broder
2Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: cbroder@usuhs.mil
DOI: 10.1128/JVI.01619-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    NiV susceptibility study body temperatures and respiration rates. (A) Rectal temperatures obtained at various days postinfection in cats inoculated with either 500 TCID50 of NiV (circles) or 5,000 TCID50 of NiV (squares). All cats became febrile 6 to 8 days postinfection. (B) Respiration rates determined for cats infected with either 500 TCID50 NiV (circles) or 5,000 TCID50 NiV (squares). Immediately prior to euthanasia, all cats exhibited a marked increase in respiration rate.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Histopathology and immunohistopathology associated with NiV infection in cats. (A) Necrotizing alveolitis (arrows) in NiV-infected cat and endothelial syncytial cell (arrowhead) (HE). (B) Broncho-alveolitis in NiV-infected cat, with bronchiolar epithelial syncytial cells (arrows) and intraluminal debris (arrowhead) (HE). (C) Positive staining for NiV antigen in regions of alveolitis, including endothelial syncytial cells (arrows) (anti-NiV polyclonal antibody). (D) Positive staining for NiV antigen in bronchiolar epithelial cells (arrows) and intraluminal debris (arrowhead) (anti-NiV polyclonal antibody). Scale bar for all images = 50 μm.

  • FIG. 3.
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    NiV genome in cats detected by TaqMan PCR. Normalized, relative NiV genome levels in samples collecting during NiV infection in cats and at necropsy. TaqMan PCR CT values were determined in triplicate for the NiV genome and normalized by dividing this value by the 18S rRNA CT values for each sample. The relative NiV genome was determined by linear regression of NiV cDNA standard curves for each assay. Values are expressed as the average of all replicates. The adrenal gland, liver, lung, spleen, and lymph nodes consistently displayed the highest relative NiV genome levels, while the brain and heart frequently revealed the lowest. The genome was detectable in the blood in all cats 1 day prior to euthanasia but only detectable in the urine from cats infected with 5,000 TCID50 of NiV.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Temperature recordings of naive and sG-immunized cats infected with NiV. (A) Two cats in the vaccine efficacy study were implanted with radiotelemetry temperature transmitters prior to NiV inoculation (arrow). Cat 10 became febrile (>39°C) 7 days postinfection, while cat 9 remained clinically normal until day 11, becoming febrile on day 12, and was euthanized on day 13. Rectal temperatures were recorded during sampling periods and are indicated for each cat (circles). (B) Three cats showed gradual but slight increases in temperature after NiV infection (arrow), while the fourth showed a gradual decrease over the course of the study. All immunized cats remained within normal physiological parameters up to 24 days p.i.

Tables

  • Figures
  • TABLE 1.

    Normalized relative NiV genome levels detected by TaqMan PCR in NiV-infected naive catsa

    SampleLocationdpiRelative NiV genome level in cat (inoculum size)b:
    1 (500)2 (5,000)3 (5,000)4 (500)
    Adrenal glandPM1,083.8660.282369.0423.461
    BladderPM0.067 32.387 NS0.009
    Blood00.0000.0000.0000.000
    20.0000.0000.0000.000
    30.0000.000NSNS
    4NSNS0.0000.000
    50.0000.000NSNS
    6NSNS0.8540.000
    7NSNS0.786NS
    80.1650.125NS0.628
    90.2370.599NS0.768
    BrainOccipital lobePM0.1720.0000.62216.624
    Olfactory lobePM0.0000.4110.5780.251
    HeartPM0.0001.6697.5120.000
    KidneyPM18.974 24.599 22.421 0.000
    LiverPM0.8420.0010.33418.679
    LungApical lobePM 1,094.862 NS 973.303 1,480.818
    Diaphragmatic lobePM13.143 432.096 2,027.956 1,124.226
    Lymph nodeThoracicPM1.695NSNSNS
    PrescapularPMNSNS 486.245 NS
    Skeletal musclePMNSNS0.001NS
    SpleenPM 890.187 2,438.948 1,667.516 628.465
    Swab00.0000.0000.0000.000
    20.0000.0000.0000.000
    40.000NS0.0000.000
    5NS0.000NSNS
    6NSNS0.010NS
    7NSNS 0.798 NS
    80.0000.000NSNS
    90.0000.311NS0.017
    Urine0NS0.000NSNS
    3NS0.000NSNS
    7NSNS0.018NS
    8NS0.000NSNS
    90.0001.977NS0.000
    Uterine hornPMNS0.176NSNS
    • ↵ a Relative values were determined by linear regression analysis using NiV cDNA standards and normalized using the ratio of NiV:18S rRNA CT values. PM, postmortem tissue; dpi, days postinfection; NS, no sample. Values are expressed as the fold difference from 3.6 pg of NiV cDNA standard and are the average of all replicates. Values in boldface indicate samples from which virus was isolated.

    • ↵ b The NiV inoculum (TCID50) for each cat is indicated in parentheses.

  • TABLE 2.

    Serum neutralization titers in naive and sG-immunized cats

    Cat no. (immunogen)SNTa
    HeV at:NiV at:
    2 wk2 mo2 wk2 mo
    5 (NiV sG)1:1,2801:6401:20,4801:20,480
    6 (HeV sG)1:20,4801:20,4801:20,4801:2,560
    7 (HeV sG)1:20,4801:20,4801:20,4801:10.240
    8 (NiV sG)1:2,5601:1,2801:20,4801:20,480
    9 (control)ND<1:20ND<1:20
    10 (control)ND<1:20ND<1:20
    • ↵ a Serum neutralization titers (SNT) were determined from serum samples at 2 weeks and 2 months after the final immunization with sG. SNTs were determined for both HeV and NiV. ND, not determined.

  • TABLE 3.

    Normalized relative NiV genome levels in naive and sG-immunized catsa

    SampleLocationdpiRelative NiV genome level in cat (immunogen):
    5 (NiV sG)6 (HeV sG)7 (HeV sG)8 (NiV sG)9 (control)10 (control)
    Adrenal gland0.0000.0030.0000.00010.084709.758
    Bladder0.0000.0000.0000.000 18.265 1.218
    Blood00.0000.0000.0000.0000.0000.000
    60.0000.0000.0000.0000.0001.146
    80.0000.0000.0000.0000.0000.706
    100.0000.0000.0000.0000.108NS
    13NSNSNSNS0.561NS
    240.0000.0000.0000.000NSNS
    BrainOccipital lobePM0.0000.0010.0000.0000.0871.286
    Olfactory lobePM0.0050.0000.0000.0000.0181.095
    HeartPM0.0000.0030.0000.0000.0610.033
    KidneyPM0.0000.0000.0000.000 12.957 43.692
    LiverPM0.0000.0000.0000.000 41.321 2.419
    LungApical lobePM0.0000.0000.0000.000 851.193 2,158.535
    Diaphragmatic lobePM0.0000.0750.0000.000 868.615 1,874.764
    Lung exudate13NSNSNSNS1.465NS
    Lymph nodeThoracicPM0.0000.0000.0000.000 2,030.773 NS
    RetropharyngealPMNSNSNSNSNS 31.537
    OvaryPM0.0000.0000.0000.000 51.300 NS
    Serum60.0000.0000.0000.0000.0000.000
    80.0000.0000.0000.0000.0000.068
    100.0000.0000.0000.0000.000NS
    13NSNSNSNS0.254NS
    240.0000.0000.0000.000NSNS
    SpleenPM0.0000.0000.0000.000 1,630.840 890.055
    Swab6NSNSNSNS0.0000.000
    8NSNSNSNS0.000 0.311
    100.0000.0000.0000.0000.000NS
    13NSNSNSNS0.055NS
    240.0000.0000.0000.000NSNS
    Urine6NSNSNSNS0.000NS
    8NSNSNSNS0.0004.708
    100.0000.0000.0000.0002.897NS
    13NSNSNSNS13.914NS
    240.0000.0000.0000.000NSNS
    Uterine hornPM0.0000.0000.0000.00033.063NS
    • ↵ a Relative values were determined by linear regression analysis using NiV cDNA standards and normalized using the ratio of NiV:18S rRNA CT values. PM, postmortem tissue; dpi, days postinfection; NS, no sample. Values are expressed as the fold difference from 3.6 pg of NiV cDNA standard and are the average of all replicates. Values in boldface indicate samples from which virus was isolated.

PreviousNext
Back to top
Download PDF
Citation Tools
Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine
Bruce A. Mungall, Deborah Middleton, Gary Crameri, John Bingham, Kim Halpin, Gail Russell, Diane Green, Jennifer McEachern, L. Ian Pritchard, Bryan T. Eaton, Lin-Fa Wang, Katharine N. Bossart, Christopher C. Broder
Journal of Virology Nov 2006, 80 (24) 12293-12302; DOI: 10.1128/JVI.01619-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Feline Model of Acute Nipah Virus Infection and Protection with a Soluble Glycoprotein-Based Subunit Vaccine
Bruce A. Mungall, Deborah Middleton, Gary Crameri, John Bingham, Kim Halpin, Gail Russell, Diane Green, Jennifer McEachern, L. Ian Pritchard, Bryan T. Eaton, Lin-Fa Wang, Katharine N. Bossart, Christopher C. Broder
Journal of Virology Nov 2006, 80 (24) 12293-12302; DOI: 10.1128/JVI.01619-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Disease Models, Animal
Henipavirus Infections
Nipah virus
Viral Vaccines

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514